Hydroxychloroquine
RxNorm 5521
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 5521 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Hydroxychloroquine.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
INPrescribable
Ingredient (IN):
Hydroxychloroquine
(Atom ID: 12252144)
PTPrescribable
Designated preferred name (PT):
Hydroxychloroquine
(Atom ID: 173074)
FNPrescribable
Full form of descriptor (FN):
Hydroxychloroquine (substance)
(Atom ID: 173091)
PTPrescribable
Designated preferred name (PT):
Hydroxychloroquine-containing product
(Atom ID: 10804728)
FNPrescribable
Full form of descriptor (FN):
Product containing hydroxychloroquine (medicinal product)
(Atom ID: 9258253)
Patient Education
Hydroxychloroquine
Hydroxychloroquine is used to prevent and treat acute attacks of malaria. It is also used to treat discoid lupus erythematosus (DLE; a chronic inflammatory condition of the skin) or systemic lupus erythematosus (SLE; a chronic inflammatory condition of the body) and rheumatoid arthritis in patients whose symptoms have not improved with other treatments. Hydroxychloroquine is in a class of drugs called antimalarials. It works by killing the organisms that cause malaria. Hydroxychloroquine may work to treat rheumatoid arthritis and systemic lupus erythematosus by decreasing the activity of the immune system.
[Learn More]
* Please review the disclaimer below.